These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1642561)

  • 1. The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.
    Ben Ahmeida ET; Jennings R; Erturk M; Potter CW
    Arch Virol; 1992; 125(1-4):71-86. PubMed ID: 1642561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
    Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
    Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs.
    Ghazi HO; Potter CW; Smith TL; Jennings R
    J Med Microbiol; 1995 Jan; 42(1):53-61. PubMed ID: 7739026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines.
    Ben-Ahmeida ET; Potter CW; Gregoriadis G; Adithan C; Jennings R
    J Med Microbiol; 1994 Apr; 40(4):261-9. PubMed ID: 8151677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
    Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R
    Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice.
    Ghazi HO; Erturk M; Stannard LM; Faulkner M; Potter CW; Jennings R
    Arch Virol; 1995; 140(6):1015-31. PubMed ID: 7611875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subclass IgG responses of mice to influenza surface proteins formulated into liposomes.
    Ben Ahmeida ET; Jennings R; Tan L; Gregoriadis G; Potter CW
    Antiviral Res; 1993 Jul; 21(3):217-31. PubMed ID: 8215299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
    Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
    Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B
    Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge.
    Plante M; Jones T; Allard F; Torossian K; Gauthier J; St-Félix N; White GL; Lowell GH; Burt DS
    Vaccine; 2001 Oct; 20(1-2):218-25. PubMed ID: 11567767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.
    Tamura S; Funato H; Hirabayashi Y; Kikuta K; Suzuki Y; Nagamine T; Aizawa C; Nakagawa M; Kurata T
    Vaccine; 1990 Oct; 8(5):479-85. PubMed ID: 2251874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes.
    Scheepers K; Becht H
    Med Microbiol Immunol; 1994 Nov; 183(5):265-78. PubMed ID: 7715538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.
    Asahi Y; Yoshikawa T; Watanabe I; Iwasaki T; Hasegawa H; Sato Y; Shimada S; Nanno M; Matsuoka Y; Ohwaki M; Iwakura Y; Suzuki Y; Aizawa C; Sata T; Kurata T; Tamura S
    J Immunol; 2002 Mar; 168(6):2930-8. PubMed ID: 11884464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.
    Chen KS; Burlington DB; Quinnan GV
    J Virol; 1987 Jul; 61(7):2150-4. PubMed ID: 3586130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes.
    Hu KF; Ekström J; Merza M; Lövgren-Bengtsson K; Morein B
    Med Microbiol Immunol; 1999 May; 187(4):191-8. PubMed ID: 10363675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
    Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
    Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
    Sjölander A; Bengtsson KL; Morein B
    Vaccine; 1997 Jun; 15(9):1030-8. PubMed ID: 9261953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
    Sjölander A; Lövgren Bengtsson K; Johansson M; Morein B
    Scand J Immunol; 1996 Feb; 43(2):164-72. PubMed ID: 8633196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.
    Katz JM; Lu X; Young SA; Galphin JC
    J Infect Dis; 1997 Feb; 175(2):352-63. PubMed ID: 9203656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.